Vespa velutina chromosome 9, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525131.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124951691
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124951676
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcium and integrin-binding protein 1-like
COORDINATES: polyA evidence [ECO:0006239]
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X3
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X1
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X5
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X2
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X4
E3 ubiquitin-protein ligase TRAIP-like isoform X3
E3 ubiquitin-protein ligase TRAIP-like isoform X1
E3 ubiquitin-protein ligase TRAIP-like isoform X4
E3 ubiquitin-protein ligase TRAIP-like isoform X2
E3 ubiquitin-protein ligase TRAIP-like isoform X5
bestrophin-4-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bestrophin-4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bestrophin-4-like, transcript variant X2
bestrophin-4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bestrophin-4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bestrophin-4-like, transcript variant X5
bestrophin-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X3
RNA polymerase II-associated protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X6
RNA polymerase II-associated protein 3, transcript variant X1
RNA polymerase II-associated protein 3 isoform X1
RNA polymerase II-associated protein 3 isoform X2
mitochondrial inner membrane protease ATP23 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog, transcript variant X2
mitochondrial inner membrane protease ATP23 homolog
uncharacterized LOC124951624, transcript variant X1
uncharacterized LOC124951624, transcript variant X2
probable 26S proteasome non-ATPase regulatory subunit 3
homeotic protein empty spiracles-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeotic protein empty spiracles-like, transcript variant X1
homeotic protein empty spiracles-like, transcript variant X2
homeotic protein empty spiracles-like isoform X1
homeotic protein empty spiracles-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124951537, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124951537, transcript variant X2
fumarylacetoacetate hydrolase domain-containing protein 2, transcript variant X2
fumarylacetoacetate hydrolase domain-containing protein 2, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2 isoform X2
fumarylacetoacetate hydrolase domain-containing protein 2 isoform X1
39S ribosomal protein L35, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: MICOS complex subunit Mic60
lymphocyte antigen 6D, transcript variant X2
lymphocyte antigen 6D, transcript variant X3
lymphocyte antigen 6D, transcript variant X1
ubiquitin-like domain-containing CTD phosphatase 1
phosphatidylinositide phosphatase SAC2, transcript variant X1
phosphatidylinositide phosphatase SAC2, transcript variant X2
phosphatidylinositide phosphatase SAC2 isoform X1
phosphatidylinositide phosphatase SAC2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
maternal protein exuperantia, transcript variant X1
maternal protein exuperantia, transcript variant X4
maternal protein exuperantia, transcript variant X2
maternal protein exuperantia, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124951932, transcript variant X2
uncharacterized LOC124951932, transcript variant X4
uncharacterized protein LOC124951932 isoform X2
uncharacterized LOC124951932, transcript variant X1
uncharacterized LOC124951932, transcript variant X3
uncharacterized protein LOC124951932 isoform X1
ethanolamine-phosphate cytidylyltransferase, transcript variant X5
ethanolamine-phosphate cytidylyltransferase, transcript variant X1
ethanolamine-phosphate cytidylyltransferase, transcript variant X4
ethanolamine-phosphate cytidylyltransferase, transcript variant X3
ethanolamine-phosphate cytidylyltransferase, transcript variant X2
ethanolamine-phosphate cytidylyltransferase isoform X4
ethanolamine-phosphate cytidylyltransferase isoform X1
ethanolamine-phosphate cytidylyltransferase isoform X2
ethanolamine-phosphate cytidylyltransferase isoform X3
probable ATP-dependent RNA helicase DDX5, transcript variant X1
ATP-dependent RNA helicase dbp2-like isoform X1
probable ATP-dependent RNA helicase DDX5, transcript variant X3
probable ATP-dependent RNA helicase DDX5, transcript variant X2
probable ATP-dependent RNA helicase DDX5 isoform X2
probable ATP-dependent RNA helicase DDX5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX5, transcript variant X8
probable ATP-dependent RNA helicase DDX5, transcript variant X7
probable ATP-dependent RNA helicase DDX5 isoform X3
probable ATP-dependent RNA helicase DDX5 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA ligase 1-like, transcript variant X2
DNA ligase 1-like, transcript variant X1
uncharacterized LOC124951425, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124951425, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hepatoma-derived growth factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA-binding protein 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA-binding protein 8A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
F-actin-monooxygenase mical2b, transcript variant X5
F-actin-monooxygenase mical2b, transcript variant X1
F-actin-monooxygenase mical2b, transcript variant X2
F-actin-monooxygenase mical2b, transcript variant X3
F-actin-monooxygenase mical2b, transcript variant X9
F-actin-monooxygenase mical2b, transcript variant X8
F-actin-monooxygenase mical2b, transcript variant X4
F-actin-monooxygenase mical2b, transcript variant X6
F-actin-monooxygenase mical2b, transcript variant X7
F-actin-monooxygenase mical2b isoform X2
F-actin-monooxygenase mical2b isoform X1
F-actin-monooxygenase mical2b, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ras-related protein Rab-21, transcript variant X1
ras-related protein Rab-21, transcript variant X3
ras-related protein Rab-21, transcript variant X2
rho GTPase-activating protein 1, transcript variant X2
rho GTPase-activating protein 1, transcript variant X1
rho GTPase-activating protein 1 isoform X1
rho GTPase-activating protein 1 isoform X2
cyclic GMP-AMP synthase-like receptor, transcript variant X5
cyclic GMP-AMP synthase-like receptor, transcript variant X3
cyclic GMP-AMP synthase-like receptor, transcript variant X1
cyclic GMP-AMP synthase-like receptor, transcript variant X4
cyclic GMP-AMP synthase-like receptor, transcript variant X2
cyclic GMP-AMP synthase-like receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit J, transcript variant X2
eukaryotic translation initiation factor 3 subunit J, transcript variant X1
eukaryotic translation initiation factor 3 subunit J isoform X1
eukaryotic translation initiation factor 3 subunit J isoform X2
bifunctional glutamate/proline--tRNA ligase, transcript variant X1
bifunctional glutamate/proline--tRNA ligase, transcript variant X2
bifunctional glutamate/proline--tRNA ligase isoform X1
bifunctional glutamate/proline--tRNA ligase isoform X2
bifunctional glutamate/proline--tRNA ligase, transcript variant X3
bifunctional glutamate/proline--tRNA ligase isoform X3
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X3
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X2
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X2
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X4
neuronal acetylcholine receptor subunit alpha-7-like isoform X3
acetylcholine receptor subunit beta-like 1, transcript variant X3
acetylcholine receptor subunit beta-like 1, transcript variant X2
acetylcholine receptor subunit beta-like 1, transcript variant X1
acetylcholine receptor subunit beta-like 1, transcript variant X4
acetylcholine receptor subunit beta-like 1 isoform X2
acetylcholine receptor subunit beta-like 1 isoform X1
acetylcholine receptor subunit beta-like 1 isoform X3
acetylcholine receptor subunit beta-like 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
furin-like protease 1, transcript variant X1
furin-like protease 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
furin-like protease 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
furin-like protease 1, transcript variant X5
furin-like protease 1, isoforms 1/1-X/2 isoform X3
furin-like protease 1, transcript variant X2
cyclic AMP response element-binding protein A-like
DNA primase small subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA primase small subunit, transcript variant X1
DNA primase small subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA primase small subunit, transcript variant X3
uncharacterized protein LOC124951914 isoform X2
E3 ubiquitin-protein ligase RING1, transcript variant X2
E3 ubiquitin-protein ligase RING1, transcript variant X1
E3 ubiquitin-protein ligase RING1 isoform X2
E3 ubiquitin-protein ligase RING1 isoform X1
uncharacterized LOC124951571, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124951571, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124951571, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124951571 isoform X1
uncharacterized protein LOC124951571 isoform X2
uncharacterized protein LOC124951571 isoform X5
uncharacterized LOC124951571, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124951571 isoform X3
uncharacterized LOC124951571, transcript variant X4
uncharacterized protein LOC124951571 isoform X4
sodium-independent sulfate anion transporter-like, transcript variant X1
sodium-independent sulfate anion transporter-like, transcript variant X2
sodium-independent sulfate anion transporter-like
rhoGEF domain-containing protein gxcJ-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rhoGEF domain-containing protein gxcJ-like isoform X1
rhoGEF domain-containing protein gxcJ-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rhoGEF domain-containing protein gxcJ-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rhoGEF domain-containing protein gxcJ-like isoform X2
uncharacterized LOC124951466, transcript variant X2
uncharacterized LOC124951466, transcript variant X1
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X1
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X2
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X1
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X2
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X3
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X3
protein CLEC16A homolog, transcript variant X2
protein CLEC16A homolog, transcript variant X1
protein CLEC16A homolog, transcript variant X3
tRNA (cytosine(38)-C(5))-methyltransferase
transcription factor MafG, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor MafG, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124951582, transcript variant X2
uncharacterized LOC124951582, transcript variant X5
uncharacterized LOC124951582, transcript variant X6
uncharacterized protein LOC124951582 isoform X2
uncharacterized protein LOC124951582 isoform X4
uncharacterized protein LOC124951582 isoform X5
uncharacterized LOC124951582, transcript variant X4
uncharacterized protein LOC124951582 isoform X3
uncharacterized LOC124951582, transcript variant X3
uncharacterized LOC124951582, transcript variant X1
uncharacterized protein LOC124951582 isoform X1
uncharacterized LOC124951581, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124951581, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124951581, transcript variant X4
uncharacterized LOC124951581, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124951581, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124951581 isoform X1
uncharacterized protein LOC124951581 isoform X3
uncharacterized protein LOC124951581 isoform X2
uncharacterized protein LOC124951581 isoform X4
prominin-like protein, transcript variant X3
prominin-like protein, transcript variant X1
prominin-like protein, transcript variant X7
prominin-like protein, transcript variant X2
prominin-like protein, transcript variant X4
prominin-like protein, transcript variant X5
prominin-like protein, transcript variant X6
intraflagellar transport protein 56, transcript variant X3
intraflagellar transport protein 56, transcript variant X2
intraflagellar transport protein 56, transcript variant X1
intraflagellar transport protein 56 isoform X3
intraflagellar transport protein 56 isoform X2
intraflagellar transport protein 56 isoform X1
cytosolic Fe-S cluster assembly factor NUBP2 homolog
uridine 5'-monophosphate synthase, transcript variant X4
uridine 5'-monophosphate synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X1
uridine 5'-monophosphate synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uridine 5'-monophosphate synthase isoform X1
uridine 5'-monophosphate synthase isoform X2
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X2
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X3
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X2
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X3
helicase POLQ-like, transcript variant X5
helicase POLQ-like, transcript variant X2
helicase POLQ-like, transcript variant X1
helicase POLQ-like, transcript variant X3
helicase POLQ-like, transcript variant X4
ribosomal RNA-processing protein 8, transcript variant X1
ribosomal RNA-processing protein 8, transcript variant X2
ribosomal RNA-processing protein 8 isoform X1
ribosomal RNA-processing protein 8 isoform X2
uncharacterized LOC124951471, transcript variant X1
uncharacterized LOC124951471, transcript variant X2
uncharacterized protein LOC124951471 isoform X1
uncharacterized protein LOC124951471 isoform X2
beta-1,4-glucuronyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1, transcript variant X1
beta-1,4-glucuronyltransferase 1 isoform X2
beta-1,4-glucuronyltransferase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine protease 53-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like, transcript variant X9
protein O-mannosyl-transferase TMTC1-like, transcript variant X2
protein O-mannosyl-transferase TMTC1-like, transcript variant X1
protein O-mannosyl-transferase TMTC1-like isoform X1
protein O-mannosyl-transferase TMTC1-like, transcript variant X5
protein O-mannosyl-transferase TMTC1-like, transcript variant X8
protein O-mannosyl-transferase TMTC1-like, transcript variant X4
protein O-mannosyl-transferase TMTC1-like isoform X3
protein O-mannosyl-transferase TMTC1-like, transcript variant X6
protein O-mannosyl-transferase TMTC1-like, transcript variant X3
protein O-mannosyl-transferase TMTC1-like isoform X2
protein O-mannosyl-transferase TMTC1-like isoform X4
protein O-mannosyl-transferase TMTC1-like, transcript variant X7
protein O-mannosyl-transferase TMTC1-like isoform X5
protein O-mannosyl-transferase TMTC1-like isoform X6
myrosinase 1-like, transcript variant X2
myrosinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 166 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sarcoplasmic reticulum histidine-rich calcium-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X8
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X9
ankyrin repeat and SAM domain-containing protein 1A-like isoform X8
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X7
ankyrin repeat and SAM domain-containing protein 1A-like isoform X7
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X5
uncharacterized protein LOC124951677 isoform X5
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X10
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X11
ankyrin repeat and SAM domain-containing protein 1A-like isoform X9
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X3
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X1
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X2
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X4
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X6
uncharacterized protein LOC124951677 isoform X3
ankyrin repeat and SAM domain-containing protein 1A-like isoform X6
uncharacterized protein LOC124951677 isoform X4
uncharacterized protein LOC124951677 isoform X2
uncharacterized protein LOC124951677 isoform X1
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X12
ankyrin repeat and SAM domain-containing protein 1A-like isoform X10
transmembrane 7 superfamily member 3-like
paired box protein Pax-6-like, transcript variant X4
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X3
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like isoform X4
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X3
paired box protein Pax-6-like isoform X1
torso-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
torso-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
torso-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
torso-like protein, transcript variant X2
torso-like protein, transcript variant X6
torso-like protein, transcript variant X7
tetratricopeptide repeat protein 5-like, transcript variant X3
tetratricopeptide repeat protein 5-like, transcript variant X2
tetratricopeptide repeat protein 5-like, transcript variant X4
tetratricopeptide repeat protein 5-like, transcript variant X1
torso-like protein, transcript variant X3
uncharacterized LOC124951540, transcript variant X1
uncharacterized LOC124951540, transcript variant X2
uncharacterized protein LOC124951540 isoform X1
uncharacterized protein LOC124951540 isoform X2
DNA-directed RNA polymerase I subunit RPA12
venom dipeptidyl peptidase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
venom dipeptidyl peptidase 4, transcript variant X13
venom dipeptidyl peptidase 4, transcript variant X12
venom dipeptidyl peptidase 4, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
venom dipeptidyl peptidase 4, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
venom dipeptidyl peptidase 4, transcript variant X7
venom dipeptidyl peptidase 4, transcript variant X8
venom dipeptidyl peptidase 4, transcript variant X5
venom dipeptidyl peptidase 4, transcript variant X2
venom dipeptidyl peptidase 4, transcript variant X3
venom dipeptidyl peptidase 4, transcript variant X10
venom dipeptidyl peptidase 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
venom dipeptidyl peptidase 4, transcript variant X4
venom dipeptidyl peptidase 4, transcript variant X6
transcription termination factor, mitochondrial
putative ATP-dependent RNA helicase TDRD12, transcript variant X4
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X3
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X3
calcineurin B homologous protein 1, transcript variant X1
calcineurin B homologous protein 1, transcript variant X2
calcineurin B homologous protein 1 isoform X1
calcineurin B homologous protein 1 isoform X2
protein transport protein Sec23A, transcript variant X3
protein transport protein Sec23A, transcript variant X1
protein transport protein Sec23A, transcript variant X2
protein transport protein Sec23A isoform X2
protein transport protein Sec23A isoform X1
signal recognition particle subunit SRP68
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
intraflagellar transport protein 81 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
intraflagellar transport protein 81 homolog, transcript variant X2
intraflagellar transport protein 81 homolog, transcript variant X1
intraflagellar transport protein 81 homolog isoform X1
intraflagellar transport protein 81 homolog isoform X2
uncharacterized LOC124951651, transcript variant X1
uncharacterized LOC124951651, transcript variant X2
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X4
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X1
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X2
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X3
glyoxylate reductase/hydroxypyruvate reductase-like isoform X1
glyoxylate reductase/hydroxypyruvate reductase-like isoform X3
glyoxylate reductase/hydroxypyruvate reductase-like isoform X2
phosphatidate phosphatase LPIN2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidate phosphatase LPIN2, transcript variant X2
phosphatidate phosphatase LPIN2, transcript variant X4
phosphatidate phosphatase LPIN2, transcript variant X1
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X2
phosphatidate phosphatase LPIN2 isoform X4
phosphatidate phosphatase LPIN2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
14-3-3 protein zeta, transcript variant X6
14-3-3 protein zeta, transcript variant X7
14-3-3 protein zeta, transcript variant X4
14-3-3 protein zeta, transcript variant X2
14-3-3 protein zeta, transcript variant X1
14-3-3 protein zeta, transcript variant X5
14-3-3 protein zeta, transcript variant X3
ATP-dependent 6-phosphofructokinase, transcript variant X2
ATP-dependent 6-phosphofructokinase, transcript variant X1
ATP-dependent 6-phosphofructokinase, transcript variant X3
ATP-dependent 6-phosphofructokinase, transcript variant X5
ATP-dependent 6-phosphofructokinase, transcript variant X7
ATP-dependent 6-phosphofructokinase, transcript variant X6
ATP-dependent 6-phosphofructokinase, transcript variant X4
ATP-dependent 6-phosphofructokinase isoform X1
ATP-dependent 6-phosphofructokinase isoform X3
ATP-dependent 6-phosphofructokinase isoform X4
ATP-dependent 6-phosphofructokinase isoform X2
ATP-dependent 6-phosphofructokinase isoform X5
uncharacterized LOC124951398, transcript variant X3
uncharacterized LOC124951398, transcript variant X1
uncharacterized LOC124951398, transcript variant X2
uncharacterized protein LOC124951398 isoform X2
uncharacterized protein LOC124951398 isoform X3
uncharacterized protein LOC124951398 isoform X1
ubiquitin-conjugating enzyme E2 J1-like, transcript variant X2
ubiquitin-conjugating enzyme E2 J1-like, transcript variant X3
ubiquitin-conjugating enzyme E2 J1-like, transcript variant X1
5-hydroxytryptamine receptor 2A, transcript variant X5
5-hydroxytryptamine receptor 2A, transcript variant X3
5-hydroxytryptamine receptor 2A, transcript variant X2
5-hydroxytryptamine receptor 2A, transcript variant X1
5-hydroxytryptamine receptor 2A, transcript variant X6
5-hydroxytryptamine receptor 2A, transcript variant X4
5-hydroxytryptamine receptor 2A isoform X2
5-hydroxytryptamine receptor 2A isoform X1
ras-related protein Rab6, transcript variant X1
ras-related protein Rab6, transcript variant X2
neuroligin-4, X-linked, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuroligin-4, X-linked, transcript variant X2
neuroligin-4, X-linked, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124951668, transcript variant X1
uncharacterized LOC124951668, transcript variant X5
uncharacterized LOC124951668, transcript variant X3
uncharacterized LOC124951668, transcript variant X2
uncharacterized LOC124951668, transcript variant X4
uncharacterized protein LOC124951668 isoform X1
uncharacterized protein LOC124951668 isoform X3
uncharacterized protein LOC124951668 isoform X2
neuroligin-4, X-linked-like, transcript variant X3
neuroligin-4, X-linked-like, transcript variant X1
neuroligin-4, X-linked-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein arginine N-methyltransferase 9-like, transcript variant X4
protein arginine N-methyltransferase 9-like, transcript variant X1
protein arginine N-methyltransferase 9-like, transcript variant X3
protein arginine N-methyltransferase 9-like, transcript variant X2
protein arginine N-methyltransferase 9-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X6
protein arginine N-methyltransferase 9-like, transcript variant X8
protein arginine N-methyltransferase 9-like, transcript variant X5
protein arginine N-methyltransferase 9-like isoform X1
protein arginine N-methyltransferase 9-like isoform X2
protein arginine N-methyltransferase 9-like isoform X3
protein arginine N-methyltransferase 9-like isoform X5
protein arginine N-methyltransferase 9-like, transcript variant X7
protein arginine N-methyltransferase 9-like isoform X4
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial, transcript variant X1
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial, transcript variant X2
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X1
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X2
M cell-type agglutination protein mam3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methyltransferase-like protein 17, mitochondrial, transcript variant X2
methyltransferase-like protein 17, mitochondrial, transcript variant X1
methyltransferase-like protein 17, mitochondrial, transcript variant X3
methyltransferase-like protein 17, mitochondrial
GON-4-like protein, transcript variant X4
GON-4-like protein, transcript variant X5
GON-4-like protein, transcript variant X3
GON-4-like protein, transcript variant X2
GON-4-like protein, transcript variant X1
phosphorylated adapter RNA export protein
exosome complex exonuclease RRP42-like, transcript variant X1
exosome complex exonuclease RRP42-like, transcript variant X2
exosome complex exonuclease RRP42-like isoform X1
exosome complex exonuclease RRP42-like isoform X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X2
uncharacterized LOC124951501, transcript variant X2
uncharacterized LOC124951501, transcript variant X1
uncharacterized LOC124951501, transcript variant X3
uncharacterized LOC124951501, transcript variant X4
uncharacterized protein LOC124951501 isoform X2
uncharacterized protein LOC124951501 isoform X1
uncharacterized protein LOC124951501 isoform X3
uncharacterized protein LOC124951501 isoform X4
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
early endosome antigen 1-like, transcript variant X8
early endosome antigen 1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
integrator complex subunit 11, transcript variant X2
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11, transcript variant X3
early endosome antigen 1-like, transcript variant X6
early endosome antigen 1-like, transcript variant X4
early endosome antigen 1-like, transcript variant X3
early endosome antigen 1-like, transcript variant X1
early endosome antigen 1-like, transcript variant X5
early endosome antigen 1-like, transcript variant X9
early endosome antigen 1-like, transcript variant X7
early endosome antigen 1-like, transcript variant X2
early endosome antigen 1-like isoform X4
osteoclast-stimulating factor 1-like, transcript variant X5
osteoclast-stimulating factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
osteoclast-stimulating factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
osteoclast-stimulating factor 1-like, transcript variant X2
osteoclast-stimulating factor 1-like, transcript variant X4
GATA zinc finger domain-containing protein 10-like, transcript variant X4
GATA zinc finger domain-containing protein 10-like, transcript variant X3
GATA zinc finger domain-containing protein 10-like, transcript variant X1
GATA zinc finger domain-containing protein 10-like, transcript variant X2
GATA zinc finger domain-containing protein 10-like, transcript variant X5
GATA zinc finger domain-containing protein 10-like isoform X1
GATA zinc finger domain-containing protein 10-like isoform X2
GATA zinc finger domain-containing protein 10-like isoform X3
uncharacterized LOC124951732, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC124951732 isoform X1
uncharacterized LOC124951732, transcript variant X3
uncharacterized LOC124951732, transcript variant X2
uncharacterized LOC124951732, transcript variant X4
uncharacterized LOC124951732, transcript variant X5
uncharacterized protein LOC124951732 isoform X2
uncharacterized LOC124951734, transcript variant X2
uncharacterized LOC124951734, transcript variant X1
uncharacterized LOC124951733, transcript variant X2
uncharacterized LOC124951733, transcript variant X5
uncharacterized LOC124951733, transcript variant X1
uncharacterized LOC124951733, transcript variant X3
uncharacterized LOC124951733, transcript variant X4
uncharacterized LOC124951733, transcript variant X7
uncharacterized LOC124951733, transcript variant X9
uncharacterized LOC124951733, transcript variant X6
uncharacterized LOC124951733, transcript variant X8
uncharacterized LOC124951735, transcript variant X2
uncharacterized LOC124951735, transcript variant X1
uncharacterized LOC124951735, transcript variant X3
zinc finger and SCAN domain-containing protein 23-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 23-like, transcript variant X2
oocyte zinc finger protein XlCOF6-like isoform X1
zinc finger and SCAN domain-containing protein 23-like isoform X2
cytochrome c oxidase subunit 5A, mitochondrial
DNA-binding protein P3A2, transcript variant X2
DNA-binding protein P3A2, transcript variant X4
DNA-binding protein P3A2, transcript variant X5
DNA-binding protein P3A2, transcript variant X1
DNA-binding protein P3A2, transcript variant X3
DNA-binding protein P3A2, transcript variant X6
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X2
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X3
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X1
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X2
scm-like with four MBT domains protein 1, transcript variant X5
scm-like with four MBT domains protein 1, transcript variant X4
scm-like with four MBT domains protein 1, transcript variant X3
scm-like with four MBT domains protein 1, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X1
scm-like with four MBT domains protein 1 isoform X2
scm-like with four MBT domains protein 2 isoform X3
scm-like with four MBT domains protein 1 isoform X1
peptide chain release factor 1-like, mitochondrial, transcript variant X2
peptide chain release factor 1-like, mitochondrial, transcript variant X1
peptide chain release factor 1-like, mitochondrial isoform X1
peptide chain release factor 1-like, mitochondrial isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X6
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X10
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X11
protein rolling stone-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein rolling stone-like, transcript variant X3
protein rolling stone-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
F-box/WD repeat-containing protein 9-like
solute carrier family 52, riboflavin transporter, member 3-A-like
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X1
uncharacterized LOC124951745, transcript variant X1
uncharacterized LOC124951745, transcript variant X2
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124951750, transcript variant X3
uncharacterized LOC124951750, transcript variant X2
uncharacterized LOC124951750, transcript variant X1
uncharacterized LOC124951750, transcript variant X4
bromodomain-containing protein 7, transcript variant X1
bromodomain-containing protein 7, transcript variant X9
bromodomain-containing protein 7, transcript variant X5
bromodomain-containing protein 7, transcript variant X4
bromodomain-containing protein 7, transcript variant X8
bromodomain-containing protein 7, transcript variant X7
bromodomain-containing protein 7, transcript variant X6
bromodomain-containing protein 7, transcript variant X3
bromodomain-containing protein 7, transcript variant X2
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X2
solute carrier family 12 member 6, transcript variant X8
solute carrier family 12 member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 12 member 6, transcript variant X2
solute carrier family 12 member 6, transcript variant X1
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 12 member 4 isoform X5
solute carrier family 12 member 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 12 member 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 12 member 6, transcript variant X4
solute carrier family 12 member 4 isoform X4
solute carrier family 12 member 6 isoform X6
NGFI-A-binding protein homolog, transcript variant X7
NGFI-A-binding protein homolog, transcript variant X8
NGFI-A-binding protein homolog, transcript variant X4
NGFI-A-binding protein homolog, transcript variant X9
NGFI-A-binding protein homolog, transcript variant X1
NGFI-A-binding protein homolog, transcript variant X10
NGFI-A-binding protein homolog, transcript variant X13
NGFI-A-binding protein homolog, transcript variant X6
NGFI-A-binding protein homolog, transcript variant X2
NGFI-A-binding protein homolog, transcript variant X3
NGFI-A-binding protein homolog, transcript variant X5
NGFI-A-binding protein homolog isoform X6
NGFI-A-binding protein homolog isoform X4
NGFI-A-binding protein homolog isoform X5
NGFI-A-binding protein homolog isoform X2
NGFI-A-binding protein homolog isoform X3
NGFI-A-binding protein homolog isoform X1
NGFI-A-binding protein homolog isoform X11
NGFI-A-binding protein homolog, transcript variant X11
NGFI-A-binding protein homolog, transcript variant X12
NGFI-A-binding protein homolog isoform X10
NGFI-A-binding protein homolog isoform X8
NGFI-A-binding protein homolog isoform X9
NGFI-A-binding protein homolog isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dnaJ homolog subfamily C member 16, transcript variant X1
dnaJ homolog subfamily C member 16 isoform X1
dnaJ homolog subfamily C member 16, transcript variant X2
dnaJ homolog subfamily C member 16, transcript variant X3
dnaJ homolog subfamily C member 16 isoform X2
dnaJ homolog subfamily C member 16 isoform X3
MICOS complex subunit Mic10-like, transcript variant X1
MICOS complex subunit Mic10-like, transcript variant X2
ribonuclease P protein subunit p30, transcript variant X2
ribonuclease P protein subunit p30, transcript variant X1
aryl hydrocarbon receptor protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl hydrocarbon receptor protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aryl hydrocarbon receptor protein 1 isoform X1
aryl hydrocarbon receptor protein 1 isoform X4
aryl hydrocarbon receptor protein 1, transcript variant X4
aryl hydrocarbon receptor protein 1, transcript variant X2
uncharacterized protein LOC124951519 isoform X2
aryl hydrocarbon receptor protein 1, transcript variant X3
uncharacterized protein LOC124951519 isoform X3
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
integrin alpha-8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
integrin alpha-8-like, transcript variant X1
integrin alpha-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized serine-rich protein C215.13-like, transcript variant X2
uncharacterized serine-rich protein C215.13-like, transcript variant X1
uncharacterized serine-rich protein C215.13-like
uncharacterized LOC124951788, transcript variant X2
uncharacterized LOC124951788, transcript variant X4
uncharacterized LOC124951788, transcript variant X3
uncharacterized LOC124951788, transcript variant X1
sterol carrier protein 2, transcript variant X2
sterol carrier protein 2, transcript variant X1
D(1)-like dopamine receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
D(1)-like dopamine receptor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
D(1)-like dopamine receptor, transcript variant X4
D(1)-like dopamine receptor, transcript variant X6
D(1)-like dopamine receptor, transcript variant X2
D(1)-like dopamine receptor, transcript variant X7
D(1)-like dopamine receptor, transcript variant X8
D(1)-like dopamine receptor, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
D(1)-like dopamine receptor, transcript variant X3
alpha-1B adrenergic receptor-like isoform X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X2
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X4
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X2
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X5
casein kinase II subunit alpha, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X5
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha, transcript variant X7
casein kinase II subunit alpha, transcript variant X4
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
transmembrane protein 64, transcript variant X2
transmembrane protein 64, transcript variant X1
translational activator of cytochrome c oxidase 1
exosome complex component RRP45, transcript variant X1
exosome complex component RRP45, transcript variant X2
exosome complex component RRP45, transcript variant X3
exosome complex component RRP45 isoform X1
exosome complex component RRP45 isoform X2
exosome complex component RRP45 isoform X3
histone deacetylase complex subunit SAP30 homolog, transcript variant X1
histone deacetylase complex subunit SAP30 homolog, transcript variant X2
histone deacetylase complex subunit SAP30 homolog isoform X1
histone deacetylase complex subunit SAP30 homolog isoform X2
60S ribosomal protein L31, transcript variant X2
60S ribosomal protein L31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133, transcript variant X3
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
putative uncharacterized protein DDB_G0282133, transcript variant X4
putative uncharacterized protein DDB_G0282133, transcript variant X5
putative uncharacterized protein DDB_G0282133
uncharacterized LOC124951820, transcript variant X2
uncharacterized LOC124951820, transcript variant X1
uncharacterized protein LOC124951820 isoform X2
uncharacterized protein LOC124951820 isoform X1
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, transcript variant X3
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, transcript variant X1
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, transcript variant X2
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
muscarinic acetylcholine receptor DM1, transcript variant X8
muscarinic acetylcholine receptor DM1, transcript variant X7
muscarinic acetylcholine receptor DM1, transcript variant X6
muscarinic acetylcholine receptor DM1, transcript variant X9
muscarinic acetylcholine receptor DM1, transcript variant X10
muscarinic acetylcholine receptor DM1, transcript variant X11
muscarinic acetylcholine receptor DM1, transcript variant X1
muscarinic acetylcholine receptor DM1, transcript variant X3
muscarinic acetylcholine receptor DM1, transcript variant X4
muscarinic acetylcholine receptor DM1, transcript variant X5
muscarinic acetylcholine receptor DM1, transcript variant X2
muscarinic acetylcholine receptor DM1 isoform X2
muscarinic acetylcholine receptor DM1 isoform X1
muscarinic acetylcholine receptor DM1, transcript variant X12
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glutamate-gated chloride channel
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 6B1-like, transcript variant X1
cytochrome P450 6B1-like, transcript variant X4
cytochrome P450 6B1-like, transcript variant X2
cytochrome P450 6B1-like, transcript variant X3
probable cytochrome P450 6a21 isoform X3
ionotropic receptor 75a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ionotropic receptor 75a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ejaculatory bulb-specific protein 3-like
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X3
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X2
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X1
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X4
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X5
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X6
aldehyde dehydrogenase, dimeric NADP-preferring isoform X3
aldehyde dehydrogenase, dimeric NADP-preferring isoform X2
aldehyde dehydrogenase, dimeric NADP-preferring isoform X1
aldehyde dehydrogenase, dimeric NADP-preferring isoform X4
aldehyde dehydrogenase, dimeric NADP-preferring isoform X5
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X7
putative glycerol kinase 5, transcript variant X2
putative glycerol kinase 5, transcript variant X3
putative glycerol kinase 5, transcript variant X1
nuclear transcription factor Y subunit beta-like
AF4/FMR2 family member lilli-like, transcript variant X4
AF4/FMR2 family member lilli-like isoform X4
AF4/FMR2 family member lilli-like, transcript variant X5
AF4/FMR2 family member lilli-like, transcript variant X2
AF4/FMR2 family member lilli-like isoform X5
AF4/FMR2 family member lilli-like isoform X2
AF4/FMR2 family member lilli-like, transcript variant X1
AF4/FMR2 family member lilli-like, transcript variant X3
AF4/FMR2 family member lilli-like isoform X1
AF4/FMR2 family member lilli-like, transcript variant X8
AF4/FMR2 family member lilli-like isoform X3
AF4/FMR2 family member lilli-like, transcript variant X6
AF4/FMR2 family member lilli-like isoform X6
AF4/FMR2 family member lilli-like, transcript variant X7
mediator of RNA polymerase II transcription subunit 29
serum response factor homolog, transcript variant X1
serum response factor homolog, transcript variant X2
serum response factor homolog isoform X1
serum response factor homolog isoform X2
electron transfer flavoprotein subunit beta
CDC42 small effector protein homolog, transcript variant X4
CDC42 small effector protein homolog, transcript variant X3
CDC42 small effector protein homolog, transcript variant X2
CDC42 small effector protein homolog, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X2
dnaJ homolog subfamily C member 7 isoform X1
dnaJ homolog subfamily C member 7 isoform X2
uncharacterized LOC124951612, transcript variant X5
uncharacterized LOC124951612, transcript variant X2
uncharacterized LOC124951612, transcript variant X1
uncharacterized LOC124951612, transcript variant X6
uncharacterized LOC124951612, transcript variant X3
uncharacterized protein LOC124951612 isoform X4
uncharacterized protein LOC124951612 isoform X1
uncharacterized protein LOC124951612 isoform X5
uncharacterized protein LOC124951612 isoform X2
uncharacterized LOC124951612, transcript variant X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
uncharacterized protein LOC124951612 isoform X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X2
trithorax group protein osa, transcript variant X1
trithorax group protein osa, transcript variant X2
trithorax group protein osa, transcript variant X3
trithorax group protein osa, transcript variant X4
trithorax group protein osa, transcript variant X7
trithorax group protein osa, transcript variant X6
trithorax group protein osa, transcript variant X5
vacuolar protein sorting-associated protein 13C-like, transcript variant X3
vacuolar protein sorting-associated protein 13C-like, transcript variant X2
vacuolar protein sorting-associated protein 13C-like, transcript variant X1
vacuolar protein sorting-associated protein 13C-like, transcript variant X5
vacuolar protein sorting-associated protein 13C-like isoform X3
vacuolar protein sorting-associated protein 13C-like isoform X2
vacuolar protein sorting-associated protein 13C-like isoform X1
vacuolar protein sorting-associated protein 13C-like isoform X5
vacuolar protein sorting-associated protein 13C-like, transcript variant X4
vacuolar protein sorting-associated protein 13C-like isoform X4
uncharacterized LOC124951609, transcript variant X7
uncharacterized LOC124951609, transcript variant X9
uncharacterized LOC124951609, transcript variant X8
uncharacterized LOC124951609, transcript variant X1
uncharacterized LOC124951609, transcript variant X2
uncharacterized LOC124951609, transcript variant X3
uncharacterized LOC124951609, transcript variant X5
uncharacterized LOC124951609, transcript variant X4
uncharacterized LOC124951609, transcript variant X6
uncharacterized protein LOC124951609 isoform X2
uncharacterized protein LOC124951609 isoform X4
uncharacterized protein LOC124951609 isoform X3
uncharacterized protein LOC124951609 isoform X1
iduronate 2-sulfatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X3
iduronate 2-sulfatase, transcript variant X1
uncharacterized LOC124951941, transcript variant X1
uncharacterized LOC124951941, transcript variant X2
L-ascorbate oxidase-like, transcript variant X1
L-ascorbate oxidase-like, transcript variant X3
L-ascorbate oxidase-like, transcript variant X2
SAC3 domain-containing protein 1, transcript variant X2
SAC3 domain-containing protein 1, transcript variant X1
SAC3 domain-containing protein 1, transcript variant X3
SAC3 domain-containing protein 1 isoform X1
SAC3 domain-containing protein 1 isoform X3
mediator of RNA polymerase II transcription subunit 4, transcript variant X2
mediator of RNA polymerase II transcription subunit 4, transcript variant X1
mediator of RNA polymerase II transcription subunit 4 isoform X2
mediator of RNA polymerase II transcription subunit 4 isoform X1
39S ribosomal protein L4, mitochondrial, transcript variant X2
39S ribosomal protein L4, mitochondrial isoform X2
DNA replication complex GINS protein PSF1-like
39S ribosomal protein L4, mitochondrial, transcript variant X1
39S ribosomal protein L4, mitochondrial isoform X1
uncharacterized LOC124951832, transcript variant X2
uncharacterized LOC124951832, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC124951832 isoform X2
uncharacterized protein LOC124951832 isoform X1
glycine-rich protein DOT1-like, transcript variant X7
uncharacterized LOC124951825, transcript variant X2
uncharacterized LOC124951825, transcript variant X1
uncharacterized protein LOC124951825 isoform X2
uncharacterized protein LOC124951825 isoform X1
glycine-rich protein DOT1-like, transcript variant X2
glycine-rich protein DOT1-like, transcript variant X6
glycine-rich protein DOT1-like, transcript variant X4
glycine-rich protein DOT1-like, transcript variant X5
glycine-rich protein DOT1-like, transcript variant X1
glycine-rich protein DOT1-like, transcript variant X3
ATPase family protein 2 homolog, transcript variant X1
ATPase family protein 2 homolog, transcript variant X2
uncharacterized protein LOC124951769 isoform X2
uncharacterized protein LOC124951769 isoform X3
intraflagellar transport protein 43 homolog, transcript variant X1
intraflagellar transport protein 43 homolog, transcript variant X2
intraflagellar transport protein 43 homolog isoform X1
intraflagellar transport protein 43 homolog isoform X2
endoplasmic reticulum lectin 1, transcript variant X2
endoplasmic reticulum lectin 1, transcript variant X1
mitochondrial import receptor subunit TOM40 homolog 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum lectin 1 isoform X2
endoplasmic reticulum lectin 1 isoform X1
protein CASC3-like, transcript variant X1
protein CASC3-like, transcript variant X2
orexin/Hypocretin receptor type 1-like, transcript variant X7
orexin/Hypocretin receptor type 1-like isoform X2
orexin/Hypocretin receptor type 1-like, transcript variant X10
orexin/Hypocretin receptor type 1-like, transcript variant X9
orexin/Hypocretin receptor type 1-like, transcript variant X8
orexin/Hypocretin receptor type 1-like, transcript variant X5
orexin/Hypocretin receptor type 1-like, transcript variant X1
orexin/Hypocretin receptor type 1-like, transcript variant X2
orexin/Hypocretin receptor type 1-like, transcript variant X3
orexin/Hypocretin receptor type 1-like, transcript variant X4
orexin/Hypocretin receptor type 1-like, transcript variant X6
orexin/Hypocretin receptor type 1-like isoform X1
LOW QUALITY PROTEIN: uncharacterized protein LOC124951772
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
protein croquemort, transcript variant X4
protein croquemort, transcript variant X1
protein croquemort, transcript variant X3
protein croquemort, transcript variant X2
intraflagellar transport protein 57 homolog
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
histone deacetylase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histone deacetylase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histone deacetylase 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone deacetylase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GPI mannosyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GPI mannosyltransferase 4, transcript variant X1
proteasome assembly chaperone 1, transcript variant X2
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1 isoform X2
proteasome assembly chaperone 1 isoform X1
delta(14)-sterol reductase TM7SF2, transcript variant X3
delta(14)-sterol reductase LBR isoform X3
delta(14)-sterol reductase TM7SF2, transcript variant X2
delta(14)-sterol reductase TM7SF2, transcript variant X1
delta(14)-sterol reductase TM7SF2 isoform X2
delta(14)-sterol reductase LBR isoform X1
heat shock factor 2-binding protein-like, transcript variant X2
heat shock factor 2-binding protein-like, transcript variant X1
heat shock factor 2-binding protein-like isoform X1
heat shock factor 2-binding protein-like isoform X2
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3 isoform X4
uncharacterized LOC124951469, transcript variant X2
uncharacterized LOC124951469, transcript variant X1
uncharacterized LOC124951469, transcript variant X3
monocarboxylate transporter 3, transcript variant X6
monocarboxylate transporter 3 isoform X6
monocarboxylate transporter 3, transcript variant X7
monocarboxylate transporter 3, transcript variant X8
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X3
monocarboxylate transporter 3 isoform X2
monocarboxylate transporter 12 isoform X8
monocarboxylate transporter 12 isoform X7
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3 isoform X5
uncharacterized LOC124951656, transcript variant X2
uncharacterized LOC124951656, transcript variant X1
uncharacterized protein LOC124951656 isoform X1
uncharacterized protein LOC124951656 isoform X2
lysM and putative peptidoglycan-binding domain-containing protein 3
uncharacterized LOC124951655, transcript variant X6
uncharacterized LOC124951655, transcript variant X9
uncharacterized LOC124951655, transcript variant X2
uncharacterized LOC124951655, transcript variant X3
uncharacterized LOC124951655, transcript variant X1
uncharacterized LOC124951655, transcript variant X8
uncharacterized LOC124951655, transcript variant X7
uncharacterized LOC124951655, transcript variant X5
uncharacterized LOC124951655, transcript variant X4
tyrosine-protein phosphatase non-receptor type 14, transcript variant X3
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14 isoform X2
tyrosine-protein phosphatase non-receptor type 14 isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform
scaffold protein salvador-like, transcript variant X5
scaffold protein salvador-like, transcript variant X1
scaffold protein salvador-like, transcript variant X2
scaffold protein salvador-like, transcript variant X3
scaffold protein salvador-like, transcript variant X4
scaffold protein salvador-like, transcript variant X6
scaffold protein salvador-like isoform X1
scaffold protein salvador-like isoform X2
protein salvador homolog 1-like isoform X3
scaffold protein salvador-like isoform X4
scaffold protein salvador-like isoform X5
uncharacterized LOC124951847, transcript variant X1
uncharacterized LOC124951847, transcript variant X3
uncharacterized LOC124951847, transcript variant X2
probable cytochrome P450 6a17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 148 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable cytochrome P450 6a17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 148 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable cytochrome P450 6a17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 148 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 6a17, transcript variant X4
nuclear inhibitor of protein phosphatase 1, transcript variant X3
nuclear inhibitor of protein phosphatase 1, transcript variant X2
nuclear inhibitor of protein phosphatase 1, transcript variant X1
nuclear inhibitor of protein phosphatase 1 isoform X1
nuclear inhibitor of protein phosphatase 1 isoform X2
clustered-asparagine-rich protein-like, transcript variant X2
clustered-asparagine-rich protein-like, transcript variant X3
clustered-asparagine-rich protein-like, transcript variant X4
clustered-asparagine-rich protein-like, transcript variant X1
thioredoxin, mitochondrial, transcript variant X6
thioredoxin, mitochondrial, transcript variant X4
thioredoxin, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thioredoxin, mitochondrial, transcript variant X7
thioredoxin, mitochondrial, transcript variant X3
thioredoxin, mitochondrial, transcript variant X2
thioredoxin, mitochondrial, transcript variant X1
pecanex-like protein 1, transcript variant X1
pecanex-like protein 1, transcript variant X2
pecanex-like protein 1, transcript variant X3
pecanex-like protein 1, transcript variant X4
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X2
mitogen-activated protein kinase kinase kinase 11-like isoform X1
mitogen-activated protein kinase kinase kinase 11-like isoform X2
galactose mutarotase-like, transcript variant X1
galactose mutarotase-like, transcript variant X2
galactose mutarotase-like, transcript variant X3
galactose mutarotase-like, transcript variant X4
ATP-dependent DNA helicase DDX11, transcript variant X6
ATP-dependent DNA helicase DDX11, transcript variant X3
ATP-dependent DNA helicase DDX11, transcript variant X4
ATP-dependent DNA helicase DDX11, transcript variant X2
ATP-dependent DNA helicase DDX11, transcript variant X5
ATP-dependent DNA helicase DDX11, transcript variant X1
ATP-dependent DNA helicase DDX11 isoform X3
putative ATP-dependent RNA helicase DDX12 isoform X5
putative ATP-dependent RNA helicase DDX12 isoform X4
ATP-dependent DNA helicase DDX11 isoform X2
ATP-dependent DNA helicase DDX11 isoform X1
eukaryotic translation initiation factor 3 subunit F
26S proteasome non-ATPase regulatory subunit 8
probable 39S ribosomal protein L49, mitochondrial
uncharacterized LOC124951577, transcript variant X2
uncharacterized LOC124951577, transcript variant X4
uncharacterized LOC124951577, transcript variant X3
uncharacterized LOC124951577, transcript variant X1
uncharacterized LOC124951577, transcript variant X5
glutaredoxin-related protein 5, mitochondrial, transcript variant X1
glutaredoxin-related protein 5, mitochondrial, transcript variant X2
glutaredoxin-related protein 5, mitochondrial, transcript variant X4
glutaredoxin-related protein 5, mitochondrial isoform X1
glutaredoxin-related protein 5, mitochondrial isoform X2
glutaredoxin-related protein 5, mitochondrial, transcript variant X3
glutaredoxin-related protein 5, mitochondrial isoform X3
potassium voltage-gated channel protein eag-like, transcript variant X1
potassium voltage-gated channel protein eag-like, transcript variant X5
potassium voltage-gated channel protein eag-like, transcript variant X3
potassium voltage-gated channel protein eag-like, transcript variant X6
potassium voltage-gated channel protein eag-like, transcript variant X2
potassium voltage-gated channel protein eag-like, transcript variant X4
potassium voltage-gated channel protein eag-like, transcript variant X7
potassium voltage-gated channel protein eag-like isoform X1
potassium voltage-gated channel protein eag-like isoform X5
potassium voltage-gated channel protein eag-like isoform X3
potassium voltage-gated channel protein eag-like isoform X6
potassium voltage-gated channel protein eag-like isoform X2
potassium voltage-gated channel protein eag-like isoform X4
potassium voltage-gated channel protein eag-like isoform X7
MTOR-associated protein MEAK7, transcript variant X5
MTOR-associated protein MEAK7, transcript variant X4
MTOR-associated protein MEAK7, transcript variant X6
MTOR-associated protein MEAK7, transcript variant X2
MTOR-associated protein MEAK7, transcript variant X1
MTOR-associated protein MEAK7, transcript variant X3
MTOR-associated protein MEAK7, transcript variant X7
zinc finger protein 706-like, transcript variant X1
zinc finger protein 706-like, transcript variant X2
E3 ubiquitin-protein ligase hyd, transcript variant X1
E3 ubiquitin-protein ligase hyd, transcript variant X3
E3 ubiquitin-protein ligase hyd, transcript variant X2
E3 ubiquitin-protein ligase UBR5 isoform X1
E3 ubiquitin-protein ligase hyd isoform X3
E3 ubiquitin-protein ligase hyd isoform X2
protein bunched, class 2/F/G isoform-like, transcript variant X5
protein bunched, class 2/F/G isoform-like, transcript variant X4
protein bunched, class 2/F/G isoform-like, transcript variant X3
protein bunched, class 2/F/G isoform-like, transcript variant X2
protein bunched, class 2/F/G isoform-like, transcript variant X1
protein bunched, class 2/F/G isoform-like isoform X3
protein bunched, class 2/F/G isoform-like isoform X2
protein bunched, class 2/F/G isoform-like isoform X1
RCC1-like G exchanging factor-like protein, transcript variant X3
RCC1-like G exchanging factor-like protein, transcript variant X1
RCC1-like G exchanging factor-like protein, transcript variant X2
RCC1-like G exchanging factor-like protein isoform X1
RCC1-like G exchanging factor-like protein isoform X2
uncharacterized LOC124951919, transcript variant X1
uncharacterized LOC124951919, transcript variant X2
uncharacterized LOC124951919, transcript variant X5
uncharacterized LOC124951919, transcript variant X4
uncharacterized LOC124951919, transcript variant X3
uncharacterized LOC124951919, transcript variant X6
uncharacterized protein LOC124951919 isoform X1
uncharacterized protein LOC124951919 isoform X2
uncharacterized protein LOC124951919 isoform X4
uncharacterized protein LOC124951919 isoform X3
uncharacterized protein LOC124951919 isoform X5
DENN domain-containing protein 1A, transcript variant X2
DENN domain-containing protein 1A, transcript variant X1
DENN domain-containing protein 1A, transcript variant X3
DENN domain-containing protein 1A isoform X2
DENN domain-containing protein 1A isoform X3
DENN domain-containing protein 1A isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 2-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 2-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 2-like
ATP-binding cassette sub-family B member 10, mitochondrial
transmembrane protein 184B, transcript variant X1
transmembrane protein 184B, transcript variant X4
transmembrane protein 184B, transcript variant X3
transmembrane protein 184B, transcript variant X2
transmembrane protein 184B, transcript variant X6
transmembrane protein 184B, transcript variant X5
RCC1 and BTB domain-containing protein 1-like, transcript variant X2
RCC1 and BTB domain-containing protein 1-like, transcript variant X1
RCC1 and BTB domain-containing protein 1-like isoform X1
RCC1 and BTB domain-containing protein 1-like isoform X2
acetylcholinesterase-like, transcript variant X1
acetylcholinesterase-like, transcript variant X4
acetylcholinesterase-like, transcript variant X2
acetylcholinesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X3
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X1
probable multidrug resistance-associated protein lethal(2)03659 isoform X3
40S ribosomal protein S21, transcript variant X1
40S ribosomal protein S21, transcript variant X2
wiskott-Aldrich syndrome protein family member 3, transcript variant X3
wiskott-Aldrich syndrome protein family member 3, transcript variant X8
wiskott-Aldrich syndrome protein family member 3, transcript variant X9
wiskott-Aldrich syndrome protein family member 3, transcript variant X5
wiskott-Aldrich syndrome protein family member 3, transcript variant X7
wiskott-Aldrich syndrome protein family member 3, transcript variant X6
wiskott-Aldrich syndrome protein family member 3, transcript variant X4
wiskott-Aldrich syndrome protein family member 3, transcript variant X2
wiskott-Aldrich syndrome protein family member 3, transcript variant X10
wiskott-Aldrich syndrome protein family member 3, transcript variant X1
wiskott-Aldrich syndrome protein family member 3
mitochondrial 2-oxodicarboxylate carrier, transcript variant X4
mitochondrial 2-oxodicarboxylate carrier, transcript variant X5
mitochondrial 2-oxodicarboxylate carrier, transcript variant X3
mitochondrial 2-oxodicarboxylate carrier, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier, transcript variant X6
mitochondrial 2-oxodicarboxylate carrier, transcript variant X1
uncharacterized LOC124951453, transcript variant X1
uncharacterized LOC124951453, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier isoform X2
mitochondrial 2-oxodicarboxylate carrier isoform X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 5 isoform X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 5 isoform X2
structural maintenance of chromosomes protein 1A-like
origin recognition complex subunit 1, transcript variant X1
origin recognition complex subunit 1, transcript variant X2
origin recognition complex subunit 1 isoform X1
origin recognition complex subunit 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 402 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
flavin-containing monooxygenase FMO GS-OX-like 2, transcript variant X2
flavin-containing monooxygenase FMO GS-OX-like 2, transcript variant X1
flavin-containing monooxygenase FMO GS-OX-like 2
serine/threonine-protein kinase 10, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase 10 isoform X7
serine/threonine-protein kinase 10 isoform X4
serine/threonine-protein kinase 10, transcript variant X2
serine/threonine-protein kinase 10, transcript variant X1
serine/threonine-protein kinase 10, transcript variant X5
serine/threonine-protein kinase 10, transcript variant X6
serine/threonine-protein kinase 10, transcript variant X4
serine/threonine-protein kinase 10, transcript variant X3
serine/threonine-protein kinase 10, transcript variant X9
serine/threonine-protein kinase 10, transcript variant X8
serine/threonine-protein kinase 10 isoform X3
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10 isoform X1
STE20-like serine/threonine-protein kinase isoform X6
STE20-like serine/threonine-protein kinase isoform X5
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2
poly(U)-binding-splicing factor half pint, transcript variant X3
poly(U)-binding-splicing factor half pint, transcript variant X1
poly(U)-binding-splicing factor half pint, transcript variant X2
poly(U)-binding-splicing factor half pint, transcript variant X8
poly(U)-binding-splicing factor half pint, transcript variant X7
poly(U)-binding-splicing factor half pint, transcript variant X6
poly(U)-binding-splicing factor half pint, transcript variant X5
poly(U)-binding-splicing factor half pint, transcript variant X4
poly(U)-binding-splicing factor half pint, transcript variant X10
poly(U)-binding-splicing factor half pint, transcript variant X9
poly(U)-binding-splicing factor half pint isoform X3
poly(U)-binding-splicing factor half pint isoform X1
poly(U)-binding-splicing factor half pint isoform X2
poly(U)-binding-splicing factor half pint isoform X6
poly(U)-binding-splicing factor half pint isoform X4
poly(U)-binding-splicing factor half pint isoform X5
histone-lysine N-trimethyltransferase SMYD5, transcript variant X2
histone-lysine N-trimethyltransferase SMYD5, transcript variant X1
histone-lysine N-trimethyltransferase SMYD5 isoform X1
histone-lysine N-trimethyltransferase SMYD5 isoform X2
small nuclear ribonucleoprotein-associated protein B, transcript variant X1
small nuclear ribonucleoprotein-associated protein B, transcript variant X2
small nuclear ribonucleoprotein-associated protein B
BRCA2-interacting transcriptional repressor EMSY, transcript variant X2
BRCA2-interacting transcriptional repressor EMSY, transcript variant X1
BRCA2-interacting transcriptional repressor EMSY isoform X2
BRCA2-interacting transcriptional repressor EMSY isoform X1
BRCA2-interacting transcriptional repressor EMSY, transcript variant X3
BRCA2-interacting transcriptional repressor EMSY isoform X3
uncharacterized LOC124951839, transcript variant X3
uncharacterized LOC124951839, transcript variant X2
uncharacterized LOC124951839, transcript variant X1
uncharacterized protein LOC124951839 isoform X1
uncharacterized protein LOC124951839 isoform X2
uncharacterized LOC124951839, transcript variant X4
uncharacterized protein LOC124951839 isoform X3
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X2
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X1
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X4
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X3
plasma membrane ascorbate-dependent reductase CYBRD1 isoform X1
plasma membrane ascorbate-dependent reductase CYBRD1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124951836 isoform X5
uncharacterized protein LOC124951836 isoform X1
uncharacterized protein LOC124951836 isoform X2
uncharacterized protein LOC124951836 isoform X3
uncharacterized protein LOC124951836 isoform X4
uncharacterized protein LOC124951836 isoform X6
DNA-directed RNA polymerase I subunit RPA43
breast cancer type 2 susceptibility protein homolog, transcript variant X4
breast cancer type 2 susceptibility protein homolog, transcript variant X3
breast cancer type 2 susceptibility protein homolog, transcript variant X1
breast cancer type 2 susceptibility protein homolog, transcript variant X2
breast cancer type 2 susceptibility protein homolog isoform X1
breast cancer type 2 susceptibility protein homolog isoform X4
breast cancer type 2 susceptibility protein-like isoform X3
breast cancer type 2 susceptibility protein homolog isoform X2
breast cancer type 2 susceptibility protein homolog, transcript variant X5
breast cancer type 2 susceptibility protein homolog, transcript variant X6
breast cancer type 2 susceptibility protein homolog isoform X5
probable serine/threonine-protein kinase yakA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
thyrotroph embryonic factor-like, transcript variant X2
thyrotroph embryonic factor-like, transcript variant X1
thyrotroph embryonic factor-like, transcript variant X4
thyrotroph embryonic factor-like, transcript variant X3
thyrotroph embryonic factor-like isoform X1
thyrotroph embryonic factor-like isoform X3
thyrotroph embryonic factor-like isoform X2
thyrotroph embryonic factor-like isoform X4
juvenile hormone epoxide hydrolase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X3
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X3
nucleoside diphosphate kinase, transcript variant X2
nucleoside diphosphate kinase, transcript variant X1
glyceraldehyde-3-phosphate dehydrogenase, testis-specific-like, transcript variant X1
glyceraldehyde-3-phosphate dehydrogenase, testis-specific-like, transcript variant X2
glyceraldehyde-3-phosphate dehydrogenase, testis-specific-like
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like
U6 snRNA-associated Sm-like protein LSm5
anion exchange protein 2, transcript variant X2
anion exchange protein 2, transcript variant X9
anion exchange protein 2, transcript variant X5
anion exchange protein 2, transcript variant X7
anion exchange protein 2, transcript variant X4
anion exchange protein 2, transcript variant X6
anion exchange protein 2, transcript variant X8
anion exchange protein 2, transcript variant X3
anion exchange protein 2, transcript variant X1
band 3 anion transport protein isoform X1
disco-interacting protein 2, transcript variant X1
disco-interacting protein 2, transcript variant X5
disco-interacting protein 2, transcript variant X6
disco-interacting protein 2, transcript variant X2
disco-interacting protein 2, transcript variant X3
disco-interacting protein 2, transcript variant X4
disco-interacting protein 2 homolog A isoform X4
uncharacterized LOC124951641, transcript variant X1
uncharacterized LOC124951641, transcript variant X2
uncharacterized protein LOC124951641 isoform X1
uncharacterized protein LOC124951641 isoform X2
spermine synthase, transcript variant X1
spermine synthase, transcript variant X2
spermine synthase, transcript variant X4
spermine synthase, transcript variant X3
storkhead-box protein 2, transcript variant X2
storkhead-box protein 2, transcript variant X3
storkhead-box protein 2, transcript variant X1
storkhead-box protein 2, transcript variant X4
CCR4-NOT transcription complex subunit 6-like, transcript variant X2
CCR4-NOT transcription complex subunit 6-like, transcript variant X1
CCR4-NOT transcription complex subunit 6-like isoform X1
uncharacterized LOC124951808, transcript variant X1
uncharacterized LOC124951808, transcript variant X2
probable serine/threonine-protein kinase DDB_G0267686
CCR4-NOT transcription complex subunit 6-like, transcript variant X3
CCR4-NOT transcription complex subunit 6-like isoform X2
uncharacterized LOC124951809, transcript variant X1
uncharacterized LOC124951809, transcript variant X2
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
28S ribosomal protein S24, mitochondrial
MKI67 FHA domain-interacting nucleolar phosphoprotein-like
odorant receptor 85f-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative odorant receptor 92a isoform X3
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X1
thyrotropin-releasing hormone-degrading ectoenzyme-like isoform X1
thyrotropin-releasing hormone-degrading ectoenzyme-like isoform X2
odorant receptor 85f-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 85f-like, transcript variant X2
odorant receptor 85f-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative odorant receptor 92a isoform X2
putative odorant receptor 92a isoform X1
putative carbonic anhydrase 3, transcript variant X2
putative carbonic anhydrase 3, transcript variant X1
putative carbonic anhydrase 3 isoform X2
putative carbonic anhydrase 3 isoform X1
TWiK family of potassium channels protein 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
acetylcholine receptor subunit alpha-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like, transcript variant X8
acetylcholine receptor subunit alpha-like, transcript variant X1
acetylcholine receptor subunit alpha-like, transcript variant X6
acetylcholine receptor subunit alpha-like, transcript variant X2
acetylcholine receptor subunit alpha-like, transcript variant X3
acetylcholine receptor subunit alpha-like isoform X1
acetylcholine receptor subunit alpha-like isoform X5
acetylcholine receptor subunit alpha-like isoform X6
acetylcholine receptor subunit alpha-like, transcript variant X4
acetylcholine receptor subunit alpha-like isoform X2
acetylcholine receptor subunit alpha-like isoform X3
acetylcholine receptor subunit alpha-like, transcript variant X5
acetylcholine receptor subunit alpha-like isoform X4
aminopeptidase N-like, transcript variant X4
aminopeptidase N-like, transcript variant X2
aminopeptidase N-like, transcript variant X1
aminopeptidase N-like, transcript variant X3
aminopeptidase N-like, transcript variant X5
twisted gastrulation protein homolog 1-A-like, transcript variant X4
twisted gastrulation protein homolog 1-A-like, transcript variant X3
uncharacterized LOC124951700, transcript variant X4
uncharacterized LOC124951700, transcript variant X5
uncharacterized LOC124951700, transcript variant X2
uncharacterized LOC124951700, transcript variant X1
uncharacterized LOC124951700, transcript variant X3
uncharacterized LOC124951700, transcript variant X6
twisted gastrulation protein homolog 1-A-like isoform X3
twisted gastrulation protein homolog 1-A-like, transcript variant X2
twisted gastrulation protein homolog 1-A-like, transcript variant X1
twisted gastrulation protein homolog 1-A-like isoform X1
twisted gastrulation protein homolog 1-A-like isoform X2
twisted gastrulation protein homolog 1-A-like, transcript variant X5
twisted gastrulation protein homolog 1-A-like isoform X4
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
S-phase kinase-associated protein 2-like, transcript variant X2
S-phase kinase-associated protein 2-like isoform X2
S-phase kinase-associated protein 2-like, transcript variant X1
S-phase kinase-associated protein 2-like isoform X1
S-phase kinase-associated protein 2-like, transcript variant X3
uncharacterized protein LOC124951699 isoform X3
MAP kinase-interacting serine/threonine-protein kinase 1, transcript variant X1
MAP kinase-interacting serine/threonine-protein kinase 1, transcript variant X2
MAP kinase-interacting serine/threonine-protein kinase 1, transcript variant X3
MAP kinase-interacting serine/threonine-protein kinase 1 isoform X1
MAP kinase-interacting serine/threonine-protein kinase 1 isoform X2
MAP kinase-interacting serine/threonine-protein kinase 1 isoform X3
uncharacterized LOC124951702, transcript variant X2
uncharacterized LOC124951702, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124951694, transcript variant X8
uncharacterized LOC124951694, transcript variant X9
uncharacterized LOC124951694, transcript variant X7
uncharacterized LOC124951694, transcript variant X3
uncharacterized LOC124951694, transcript variant X2
uncharacterized LOC124951694, transcript variant X1
uncharacterized LOC124951694, transcript variant X6
uncharacterized LOC124951694, transcript variant X5
uncharacterized LOC124951694, transcript variant X4
uncharacterized protein LOC124951694 isoform X2
uncharacterized protein LOC124951694 isoform X1
uncharacterized protein LOC124951694 isoform X3
uncharacterized protein LOC124951694 isoform X4
general transcription factor 3C polypeptide 2-like, transcript variant X1
general transcription factor 3C polypeptide 2-like, transcript variant X2
general transcription factor 3C polypeptide 2-like, transcript variant X3
general transcription factor 3C polypeptide 2-like, transcript variant X4
general transcription factor 3C polypeptide 2-like isoform X1
uncharacterized protein LOC124951781 isoform X2
uncharacterized protein LOC124951781 isoform X4
uncharacterized protein LOC124951781 isoform X3
forkhead box protein N3-like, transcript variant X2
forkhead box protein N3-like, transcript variant X1
forkhead box protein N3-like, transcript variant X5
forkhead box protein N3-like, transcript variant X4
forkhead box protein N3-like, transcript variant X6
forkhead box protein N3-like, transcript variant X3
interference hedgehog-like, transcript variant X2
interference hedgehog-like, transcript variant X1
interference hedgehog-like, transcript variant X3
growth arrest-specific protein 2-like, transcript variant X1
growth arrest-specific protein 2-like, transcript variant X2
growth arrest-specific protein 2-like isoform X2
growth arrest-specific protein 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X6
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X5
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X5
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X6
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X9
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X9
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X7
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X7
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X8
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X8
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X3
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X8
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X10
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X1
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X4
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X5
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X7
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X9
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X13
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X11
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X15
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X18
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X20
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X12
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X16
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X2
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X19
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X21
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X6
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X14
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X22
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X17
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X1
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X5
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X8
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X7
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X9
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X10
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X13
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X11
calcium/calmodulin-dependent protein kinase type II delta chain isoform X15
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X18
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X20
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X4
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X12
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X16
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X2
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X19
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X21
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X6
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X14
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X22
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X17
uncharacterized LOC124951912, transcript variant X3
uncharacterized LOC124951912, transcript variant X1
uncharacterized LOC124951912, transcript variant X2
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DDB1- and CUL4-associated factor 6-like, transcript variant X1
DDB1- and CUL4-associated factor 6-like, transcript variant X3
DDB1- and CUL4-associated factor 6-like, transcript variant X2
DDB1- and CUL4-associated factor 6-like isoform X3
DDB1- and CUL4-associated factor 6-like isoform X2
DDB1- and CUL4-associated factor 6-like isoform X1
protein PRRC1-like, transcript variant X3
protein PRRC1-like, transcript variant X2
protein PRRC1-like, transcript variant X1
cyclin-dependent kinases regulatory subunit
excitatory amino acid transporter 1-like, transcript variant X1
excitatory amino acid transporter 1-like, transcript variant X2
excitatory amino acid transporter 1-like, transcript variant X3
excitatory amino acid transporter 1-like
vacuolar protein-sorting-associated protein 25, transcript variant X3
vacuolar protein-sorting-associated protein 25, transcript variant X2
vacuolar protein-sorting-associated protein 25, transcript variant X1
vacuolar protein-sorting-associated protein 25
NEDD8-conjugating enzyme UBE2F-like, transcript variant X2
NEDD8-conjugating enzyme UBE2F-like, transcript variant X3
NEDD8-conjugating enzyme UBE2F-like, transcript variant X1
NEDD8-conjugating enzyme UBE2F-like, transcript variant X5
NEDD8-conjugating enzyme UBE2F-like, transcript variant X4
NEDD8-conjugating enzyme UBE2F-like isoform X1
NEDD8-conjugating enzyme UBE2F-like isoform X2
NEDD8-conjugating enzyme UBE2F-like isoform X4
NEDD8-conjugating enzyme UBE2F-like isoform X3
uncharacterized LOC124951887, transcript variant X1
uncharacterized LOC124951887, transcript variant X2
LOW QUALITY PROTEIN: uncharacterized protein LOC124951742
fibrous sheath-interacting protein 2, transcript variant X3
fibrous sheath-interacting protein 2, transcript variant X2
fibrous sheath-interacting protein 2, transcript variant X1
queuosine salvage protein, transcript variant X3
queuosine salvage protein, transcript variant X1
queuosine salvage protein, transcript variant X2
fibrous sheath-interacting protein 2 isoform X1
fibrous sheath-interacting protein 2, transcript variant X4
fibrous sheath-interacting protein 2 isoform X2
myb-like protein X, transcript variant X6
myb-like protein X, transcript variant X4
myb-like protein X, transcript variant X3
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X5
myb-like protein X, transcript variant X2
myb-like protein X, transcript variant X7
myb-like protein X, transcript variant X8
myb-like protein X, transcript variant X9
uncharacterized LOC124951911, transcript variant X2
uncharacterized LOC124951911, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X3
feline leukemia virus subgroup C receptor-related protein 2 isoform X3
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2 isoform X1
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X4
feline leukemia virus subgroup C receptor-related protein 2 isoform X2
feline leukemia virus subgroup C receptor-related protein 2 isoform X4
arginine/serine-rich protein PNISR, transcript variant X1
arginine/serine-rich protein PNISR, transcript variant X2
arginine/serine-rich protein PNISR, transcript variant X3
arginine/serine-rich protein PNISR isoform X1
arginine/serine-rich protein PNISR isoform X2
arginine/serine-rich protein PNISR isoform X3
tyrosine-protein kinase Btk29A, transcript variant X2
tyrosine-protein kinase Btk29A, transcript variant X1
tyrosine-protein kinase Btk29A, transcript variant X3
tyrosine-protein kinase Btk29A, transcript variant X4
tyrosine-protein kinase Btk29A, transcript variant X6
tyrosine-protein kinase Btk29A, transcript variant X7
tyrosine-protein kinase Btk29A, transcript variant X9
tyrosine-protein kinase Btk29A, transcript variant X8
tyrosine-protein kinase Btk29A isoform X3
tyrosine-protein kinase Btk29A isoform X1
tyrosine-protein kinase Btk29A isoform X2
tyrosine-protein kinase Btk29A isoform X5
tyrosine-protein kinase Btk29A isoform X6
tyrosine-protein kinase Btk29A isoform X7
tyrosine-protein kinase Btk29A, transcript variant X5
tyrosine-protein kinase Btk29A isoform X4
mediator of RNA polymerase II transcription subunit 7, transcript variant X1
mediator of RNA polymerase II transcription subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 7
uncharacterized LOC124951894, transcript variant X2
uncharacterized protein LOC124951894 isoform X2
uncharacterized LOC124951894, transcript variant X1
uncharacterized protein LOC124951894 isoform X1
serine/arginine-rich splicing factor 2, transcript variant X2
serine/arginine-rich splicing factor 2, transcript variant X1
ribosome quality control complex subunit NEMF homolog
serine/threonine-protein kinase VRK1-like
serine/threonine-protein kinase greatwall, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase greatwall, transcript variant X1
serine/threonine-protein kinase greatwall, transcript variant X3
serine/threonine-protein kinase greatwall, transcript variant X4
serine/threonine-protein kinase greatwall isoform X1
serine/threonine-protein kinase greatwall isoform X3
serine/threonine-protein kinase greatwall isoform X2
protein grainyhead, transcript variant X2
protein grainyhead, transcript variant X4
protein grainyhead, transcript variant X1
uncharacterized protein LOC124951683 isoform X4
protein grainyhead, transcript variant X3
regulator of G-protein signaling 19, transcript variant X6
regulator of G-protein signaling 19, transcript variant X2
regulator of G-protein signaling 19, transcript variant X1
regulator of G-protein signaling 19, transcript variant X4
regulator of G-protein signaling 19, transcript variant X5
regulator of G-protein signaling 19, transcript variant X3
regulator of G-protein signaling 19, transcript variant X8
regulator of G-protein signaling 19, transcript variant X7
uncharacterized LOC124951925, transcript variant X6
uncharacterized protein LOC124951927 isoform X4
uncharacterized protein LOC124951927 isoform X2
uncharacterized protein LOC124951927 isoform X3
uncharacterized protein LOC124951927 isoform X1
regulator of G-protein signaling 17 isoform X5
regulator of G-protein signaling 19 isoform X6
uncharacterized LOC124951925, transcript variant X2
uncharacterized LOC124951925, transcript variant X1
uncharacterized LOC124951925, transcript variant X3
uncharacterized LOC124951925, transcript variant X4
uncharacterized LOC124951925, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
DNA primase small subunit-like, transcript variant X5
DNA primase small subunit-like, transcript variant X4
DNA primase small subunit-like, transcript variant X2
DNA primase small subunit-like, transcript variant X1
DNA primase small subunit-like, transcript variant X3
DNA primase small subunit-like isoform X2
DNA primase small subunit-like isoform X1
DNA primase small subunit-like isoform X3
intraflagellar transport protein 74 homolog
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X1
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X2
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X2
GATA zinc finger domain-containing protein 13-like
cyclin-dependent kinase 10, transcript variant X2
cyclin-dependent kinase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 240 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UBX domain-containing protein 7, transcript variant X3
UBX domain-containing protein 7, transcript variant X1
UBX domain-containing protein 7, transcript variant X2
UBX domain-containing protein 7 isoform X1
UBX domain-containing protein 7 isoform X2
UBX domain-containing protein 7 isoform X3